Introducing Etizolam-D3, the latest benzodiazepine internal standard from Cerilliant.
|
Etizolam-D3, 1 mL, 100 ug/mL
|
E-082
|
100 µg/mL in Methanol
An internal standard suitable for quantitation of etizolam levels in urine or other matrices by LC/MS or GC/MS in forensic analysis, clinical toxicology, or urine drug testing applications. Etizolam, sold under brand names such as Etilaam, Etizola, or Depas, is a benzodiazepine analog used for the short-term treatment of insomnia, anxiety, or panic attacks. Etizolam is also sold on the designer drug market with cases of abuse noted in Europe and the US.
|
|
|
Coming soon, Cerilliant will introduce the following benzodiazepine internal standards:
P-093 Phenazepam-D4
N-088 Norchlordiazepoxide-D
5